genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2018
Valeant Pharmaceutical International
A-Lists
Top 10 Molecular Millionaires of 2018
Industry News
Valeant Sells “Female Viagra” Developer Sprout Pharma Back to Its Shareholders
Drug Discovery
Valeant Agrees to Sell iNova Pharma Business to Carlyle and Pacific Equity for $930M
Industry News
Valeant Psoriasis Drug Gets FDA Nod with Boxed Warning
A-Lists
Top 10 Molecular Millionaires
A-Lists
Top 25 Biotech Companies of 2016
Industry News
Pharming Buys Back North America Ruconest Rights from Valeant for Up to $125M
A-Lists
Top 25 Biotech Companies of 2015
News
Valeant Licenses Brodalumab from AstraZeneca for Up to $445M
Industry News
Valeant Signs Agreement to Acquire Sprout Pharmaceuticals
1
2
3
...
7
Page 1 of 7
Scroll Up
Scroll Up
